Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of SU011248 (sunitinib) continuous daily dosing in advanced gastrointestinal stromal tumor
2005-001303-19Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sunitinib in gastrointestinal stromal tumor (GIST), sponsored by Pfizer. Started Oct 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2005-001303-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001303-19.